Tumour-Infiltrating Clonal Haematopoiesis Increases the Risk of Recurrence or Death Among Patients with NSCLC and the Risk of Death From Any Cause Among Patients with Solid Tumours By Ogkologos - May 7, 2025 681 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the analysis of TRACERx and MSK-IMPACT studies Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Healthy 33-Year-Old Nurse Learned She Had Cervical Cancer and Breast Cancer... April 30, 2019 Uncle Charlie’s Promise February 23, 2021 Treatment for Children with Leukemia Also Effective for Adolescents, Young Adults February 25, 2019 Pembrolizumab Concurrent with Radiotherapy Does Not Improve the Tumour Control and... November 8, 2022 Load more HOT NEWS Mom’s Topless Photo Is Supposed To Encourage Breastfeeding, But Some Think... Sacituzumab Govitecan Demonstrates Significant Improvement in Survival in Heavily Pretreated, Locally... Abiraterone Acetate Plus Prednisone and LHRH Analogue is Active and Safe... EMA Recommends Granting a Marketing Authorisation for Germanium (68Ge) chloride /...
